D. E. Shaw & Co., Inc. Silk Road Medical Inc Transaction History

D. E. Shaw & Co., Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$16.95 - $27.04 $7.54 Million - $12 Million	-444,710 Reduced 27.8%	1,154,781 $31.2 Million
Q1 2024 May 15, 2024	BUY	$11.38 - $19.03 $1.09 Million - $1.82 Million	95,739 Added 6.37%	1,599,491 $29.3 Million
Q4 2023 Feb 14, 2024	BUY	$6.29 - $15.72 $8.57 Million - $21.4 Million	1,362,939 Added 967.91%	1,503,752 $18.5 Million
Q3 2023 Nov 14, 2023	BUY	$14.99 - $32.65 $1.8 Million - $3.91 Million	119,845 Added 571.56%	140,813 $2.11 Million
Q2 2023 Aug 14, 2023	SELL	$29.76 - $46.14 $2.52 Million - $3.91 Million	-84,714 Reduced 80.16%	20,968 $681,000
Q1 2023 May 15, 2023	BUY	$38.09 - $57.79 $3.85 Million - $5.84 Million	101,040 Added 2176.65%	105,682 $4.14 Million
Q4 2022 Feb 14, 2023	BUY	$40.54 - $56.2 $188,186 - $260,880	4,642 New	4,642 $245,000

3.48M

19.8K

Ticker SILK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,565,600
Market Cap $1.03B
Description
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.